Kaneko S, Kurosaki M, Mashiba T, Marusawa H, et al. Risk factors for hepatocellular carcinoma at baseline and 1 year after initiation of nucleos(t)ide analog therapy for chronic hepatitis B. J Med Virol 2022 Oct 12. doi: 10.1002/jmv.28210.
PMID: 36222204